KDM1A and colorectal carcinoma: Another study revealed that KDM1A was a potential marker of 5-fluorouracil resistance in CRC, and ZY0511 synergized with 5-fluorouracil in vitro to reduce the viability and migration of CRC cells to enhance the anticancer effects of 5-fluorouracil [97].